Akershus University Hospital
Lørenskog, Norway
Location status: Recruiting
NCT Number: NCT05277129
Some patients develop cognitive decline after a stroke, but we don't always understand the mechanisms. It has been proposed that a proportion of the patients develop an autoimmune immune response, and that this could potentially explain the cognitive decline in some of the patients. The current study aims to investigate this hypothesis in a subgroup of patients with stroke.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Lørenskog, Norway
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Analysis of immune responses in peripheral blood
Time frame: 1 day (subject inclusion)
Interested in participating?
Request InfoUniversity of Oslo
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03592563
Alzheimer Disease, Behavior
Hong Kong
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT06469801
Acute Brain Injury, Brain Diseases
Kansas City, Missouri, United States
View Trial DetailsNCT07822633
Brain Diseases, Cardiovascular Diseases
Yvoir, Namur, Belgium
View Trial Details